Heritage Biologics Launches Innovative Virtual Care Program

Heritage Biologics, a leader in Rare Disease Outcomes Management (RDOM), is announcing the launch of their HBnow virtual care program.

Heritage Biologics, a leader in Rare Disease Outcomes Management (RDOM), is announcing the launch of their HBnow virtual care program. The innovative HBnow program is powered by Avizia’s telehealth platform and provides an easy interface for patients. Access to Heritage Biologics’ pharmacy and nursing staff through a reliable virtual portal aims to enhance the overall patient experience.

“Our patients require specialized care, and traditional telephone interactions aren’t always effective. HBnow provides a virtual solution that connects our pharmacists and nurses to patients 24/7 in a real-time environment. A better patient experience is often the outcome as well,” says Amanda Walker, senior vice president of patient experience at Heritage Biologics.

The exciting HBnow innovation aligns well with Heritage Biologics’ leadership in the Pharmacy Patient Experience (RXPX) movement. Providing easy access to qualified care often results in better health outcomes. Heritage Biologics understands the critical needs of rare disease patients and is committed to finding better ways to improve the patient journey.

About Heritage Biologics: 
Heritage Biologics is the recognized leader in Rare Disease Outcomes Management (RDOM). We provide preeminent value-based specialty pharmacy and high performance nursing services nationwide. Heritage is credited with developing the industry’s first formalized Pharmacy Patient Experience (RXPX) program designed to ensure accountable performance-driven care for patients. We look forward to sharing our “rare tradition of care” with you and your family. Visit http://www.HeritageBiologics.com.

Avizia was acquired by American Well in July of 2018. Information on this page refers to activities that occurred prior to the acquisition and are presented for historical context. Together we provide a comprehensive acute care offering—a full end-to-end telemedicine solution for health systems and their providers.